Teleflex (TFX) to Release Quarterly Earnings on Thursday

Teleflex (NYSE:TFX - Get Free Report) is projected to announce its Q1 2025 earnings results before the market opens on Thursday, May 1st. Analysts expect the company to announce earnings of $2.84 per share and revenue of $699.37 million for the quarter. Teleflex has set its FY 2025 guidance at 13.950-14.350 EPS.

Teleflex (NYSE:TFX - Get Free Report) last issued its quarterly earnings results on Thursday, February 27th. The medical technology company reported $3.89 earnings per share for the quarter, beating the consensus estimate of $3.86 by $0.03. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. The firm had revenue of $795.40 million during the quarter, compared to the consensus estimate of $813.24 million. On average, analysts expect Teleflex to post $14 EPS for the current fiscal year and $15 EPS for the next fiscal year.

Teleflex Stock Performance

NYSE TFX traded up $0.27 during trading hours on Tuesday, hitting $135.17. The company's stock had a trading volume of 47,384 shares, compared to its average volume of 630,217. Teleflex has a 12 month low of $124.66 and a 12 month high of $249.91. The company's 50 day simple moving average is $139.36 and its two-hundred day simple moving average is $172.78. The company has a market cap of $6.27 billion, a P/E ratio of 26.87, a price-to-earnings-growth ratio of 1.73 and a beta of 1.19. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.42 and a quick ratio of 1.39.

Teleflex Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Monday, March 17th. Investors of record on Friday, March 7th were issued a $0.34 dividend. The ex-dividend date of this dividend was Friday, March 7th. This represents a $1.36 annualized dividend and a yield of 1.01%. Teleflex's payout ratio is 95.77%.

Wall Street Analysts Forecast Growth

Several equities research analysts recently commented on the company. Wells Fargo & Company reduced their price objective on Teleflex from $214.00 to $146.00 and set an "equal weight" rating for the company in a report on Friday, February 28th. Bank of America downgraded Teleflex from a "neutral" rating to an "underperform" rating and reduced their price objective for the stock from $235.00 to $140.00 in a report on Tuesday, March 4th. Mizuho set a $155.00 target price on Teleflex in a research report on Wednesday, April 16th. Raymond James cut Teleflex from an "outperform" rating to a "market perform" rating in a research report on Friday, February 28th. Finally, Piper Sandler reaffirmed a "neutral" rating and set a $140.00 price objective (down from $255.00) on shares of Teleflex in a research report on Friday, February 28th. One analyst has rated the stock with a sell rating, nine have issued a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat, Teleflex presently has an average rating of "Hold" and an average price target of $169.63.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.